Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
HKSE:02453's 14-Day RSI is ranked worse than 72.04% of 701
companies
in the Healthcare Providers & Services industry
Industry Median: 49.85
vs HKSE:02453: 50.80
Concord Healthcare Group Co (HKSE:02453) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Concord Healthcare Group Co 14-Day RSI Related Terms
HKSE:02453 vs HCA, THC, DVA: 14-Day RSI Comparison
For the Medical Care Facilities subindustry, Concord Healthcare Group Co's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Concord Healthcare Group Co 14-Day RSI vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Concord Healthcare Group Co's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Concord Healthcare Group Co's 14-Day RSI falls into.
Concord Healthcare Group Co (HKSE:02453) 14-Day RSI Calculation
The formula for calculating RSI is:
RSI
=
100
–
[ 100
/
( 1 + Average Gain
/
Average Loss )]
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Concord Healthcare Group Co (HKSE:02453) has a 14-Day RSI of 50.80 as of Aug. 30, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Concord Healthcare Group Co and its competitors. According to the industry distribution chart, Concord Healthcare Group Co ranks #505 out of 701 companies in the Healthcare Providers & Services industry, placing it in the top 72%.
Is Concord Healthcare Group Co's 14-Day RSI too high?
Concord Healthcare Group Co's current 14-Day RSI is 50.80. The Healthcare Providers & Services industry median 14-Day RSI is 49.85. Concord Healthcare Group Co's value of 50.80 is 1.9% above this industry median. Based on the distribution chart, Concord Healthcare Group Co ranks #505 out of 701 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Concord Healthcare Group Co has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Concord Healthcare Group Co's 14-Day RSI compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Concord Healthcare Group Co ranks #505 out of 701 companies for 14-Day RSI. This places Concord Healthcare Group Co in the lower half of its industry. The industry median 14-Day RSI is 49.85. Concord Healthcare Group Co's value of 50.80 is 1.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Healthcare Providers & Services company?
The median 14-Day RSI among Healthcare Providers & Services companies is 49.85, based on 701 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Concord Healthcare Group Co's current 14-Day RSI of 50.80 is 1.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Concord Healthcare Group Co and its competitors. For the Healthcare Providers & Services industry, the median 14-Day RSI is 49.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Concord Healthcare Group Co's current 14-Day RSI is 50.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concord Healthcare Group Co stock overvalued right now?
Based on GuruFocus' analysis, Concord Healthcare Group Co (HKSE:02453) is currently considered Possible Value Trap. The stock's GF Value™ is HK$8.64, compared to a current price of HK$0.82 — trading 90.5% below its estimated fair value. The current 14-Day RSI is 50.80 and 1.9% above the Healthcare Providers & Services industry median of 49.85. Concord Healthcare Group Co's overall GF Score™ is 41/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Concord Healthcare Group Co (HKSE:02453), the current 14-Day RSI is 50.80 as of Aug. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Concord Healthcare Group Co (HKSE:02453) Overvalued in 2026?
Based on GuruFocus' analysis, Concord Healthcare Group Co stock appears to be undervalued.
The current stock price of HK$0.82 is trading 90.5% below its estimated GF Value™ of HK$8.64.
GuruFocus considers Concord Healthcare Group Co to be Possible Value Trap.
Key valuation signals for HKSE:02453:
14-Day RSI: 50.80
GF Value™: HK$8.64 vs. price of HK$0.82 (90.5% below fair value)
Industry Position: 1.9% above the Healthcare Providers & Services median (#505 of 701)
No single metric tells the full story. See the HKSE:02453 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Concord Healthcare Group Co Ltd is a healthcare service provider in China that specializes in oncology. The Group owns and operates four offline self-operated medical institutions and one medical institution under construction, dedicated to providing comprehensive and specialized medical services to cancer patients. It also provides medical equipment, software, and related services to third-party medical institutions. The company's revenue is generated from its hospital business and its medical equipment, software, and related services segment. Substantially all of the company's revenue is generated from the PRC.
41GF Score
Get the complete analysis for HKSE:02453
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02453 has been successfully added to your 
